According to a new market report published by Lucintel, the future of the biopharmaceutical contract manufacturing market looks promising with opportunities in commercial and clinical applications. The global biopharmaceutical contract manufacturing market is expected to grow with a CAGR of 8% from 2020 to 2025. The major drivers for this market are increasing demand for biopharmaceuticals, cost and time saving benefits offered by contract services, and rising pharmaceutical industries leading to outsourcing services.
To download report brochure, please go to https://www.lucintel.com/biopharmaceutical-contract-manufacturing-market.aspx and click "download brochure" tab from the menu
Biopharmaceutical contract manufacturing are companies that provide comprehensive services from drug development through drug manufacturing to other companies in the biopharmaceutical industry. In this market, biologics, antisense, RNAi, & molecular therapy, and biosimilars are the major products. Lucintel forecasts that biologics will remain the largest product segment over the forecast period due to increasing stringent regulatory framework related to biologics which is forcing pharmaceutical companies to adopt for contract manufacturing services.
Within this market, process development will remain the largest service segment over the forecast period due to the presence of advanced technologies and high capital expenditure in small and medium pharmaceutical companies that are opting for contract manufacturing.
North America will remain the largest region over the forecast period due to increasing research activities related to biopharmaceutical, rising demand for biologics, and presence of major pharmaceutical companies in the region.
Lonza, Inno Biologics, Rentschler Biotechnologie, JRS Pharma, AGC Biologics, ProBioGen, Fujifilm Diosynth Biotechnologies, Toyobo, Samsung BioLogics, and Thermo Fisher Scientific are among the major suppliers in the global biopharmaceutical contract manufacturing market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global biopharmaceutical contract manufacturing market by product, service, therapeutic area, source, application, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Biopharmaceutical Contract Manufacturing Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global biopharmaceutical contract manufacturing market by product, service, therapeutic area, source, application, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Biologics
Monoclonal Antibodies (MAbs)
Recombinant Proteins
Vaccines
Antisense, RNAi (Ribonucleic Acid), & Molecular Therapy
Biosimilars
By Service [Value ($ Million) shipment analysis for 2014 – 2025]:
Process Development
Fill & Finish Operations
Analytical & QC (Quality Control) Studies
Packaging
By Therapeutic Area [Value ($ Million) shipment analysis for 2014 – 2025]:
Autoimmune Disease
Oncology
Metabolic Disease
Ophthalmology
Cardiovascular Disease
Infectious Disease
Neurology
Respiratory Disorder
Others
By Source [Value ($ Million) shipment analysis for 2014 – 2025]:
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Germany
France
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.